Case Study

Aptuit Blister Packaging Case Study

Source: Aptuit, Inc.

A client, in need of global blister packaging, had received an exorbitant estimate from a Clinical Packaging and Logistics provider other than Aptuit. In view of severe budgeting constraints, the client was searching for more economical pricing and turned to Aptuit. In addition to being able to provide exceptional cost efficiencies, Aptuit's team of clinical packaging and logistics experts includes professionals who bring a wealth of highly specialized experience in blister packaging. The original estimate from the other provider totaled $794,500 and included $557,000 for packaging and labeling; $37,500 for film and foil; and, $200,000 for blister card stock. By engineering a customized package design and through the use of specialized Uhlmann UPS1030ET equipment, Aptuit could complete the project at the following costs: $325,250 for packaging and labeling and $50,000 for film and foil for a total cost of $375,250. The client could count on a staggering cost savings of $471,750.

The customized Uhlmann UPS1030ET commercial platform is used to produce state-of-the-art blister packaging. Aptuit can develop a custom blister packaging design, using many of the equipment's optional features.

Aptuit has a record of success in packaging multiple visually identical products into finished blister packages ready for labeling. Since flexible master formats exist, easy configuration of blister packaging is possible, providing a quick start-up, and ensuring a reduced set up cost.

access the Case Study!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma